Some lower cholesterol images:
Image by DeSegura89
Researchers at Pennsylvania State University conducted a study on the benefits of peanut consumption and found that those who consumed a greater amount of peanuts had about a 35 percent reduced risk of coronary heart disease. this effect is a result of the peanuts’ ability to lower cholesterol and its antioxidant and anti-inflammatory components.
Image by DES Daughter
How the World’s Biggest Pharmaceutical Companies are turning Us All into Patients
A lot of money can be made from healthy people who believe they are sick. Pharmaceutical companies sponsor diseases and promote them to prescribers and consumers. Thirty years ago, Henry Gadsden, the head of Merck, one of the world’s largest drug companies, told Fortune magazine that he wanted Merck to be more like chewing gum maker Wrigley’s. It had long been his dream to make drugs for healthy people so that Merck could "sell to everyone." Gadsden’s dream now drives the marketing machinery of the most profitable industry on earth. Drug companies are systematically working to widen the very boundaries that define illness, and the markets for medication grow ever larger. Mild problems are redefined as serious illness and common complaints are labeled as medical conditions requiring drug treatments. Runny noses are now allergic rhinitis, PMS has become a psychiatric disorder, and hyperactive children have ADD. When it comes to conditions like high cholesterol or low bone density, being "at risk" is sold as a disease. Selling Sickness reveals how widening the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits, in turn threatening to bankrupt health-care systems all over the world. As more and more of ordinary life becomes medicalized, the industry moves ever closer to Gadsden’s dream: "selling to everyone."
Ray Moynihan, Iona Heath, and David Henry give examples of disease mongering and suggest how to prevent the growth of this practice. Selling sicknes book is organized as a series of case studies, each focused on a particular drug. Each chapter explores a different aspect of drug marketing, with evidence drawn from published editorials, news reports, academic journals, and, most interestingly, original interviews with physician-spokespersons and pharmaceutical sales experts.
* amazon book reviews.
* Newsweek Interview with Ray Moynihan.
* Selling sickness: the pharmaceutical industry and disease mongering, BMJ, PMC1122833, Apr 13, 2002.
* Drug companies profit hugely from creating “diseases,” then the “cures”, CCPA, publications/monitor, September 1, 2005.
* The Fight against Disease Mongering: Generating Knowledge for Action, PLoS Med., PMC1434508, Apr 2006; 3(4): e191.
* Our posts tagged Alan Cassels, DrugMoney